Skip to main content
Signal8

Westlake BioPartners Opportunity Fund I, L.P.

SEC insider (Form 3/4/5 filer). CIK 0001811946. 10% Owner at Kyverna Therapeutics, Inc. (KYTX). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 18, 2025. Located in WESTLAKE VILLAGE, CA.

Companies Westlake BioPartners Opportunity Fund I, L.P. has filed insider reports for

  • Kyverna Therapeutics, Inc. (KYTX): 10% Owner
Westlake BioPartners Opportunity Fund I, L.P. profile photo

Westlake BioPartners Opportunity Fund I, L.P.

CIK: 0001811946

Transaction Breakdown

Open Market Buys (P)1 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Kyverna Therapeutics, Inc. logo
KYTX

Kyverna Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Kyverna Therapeutics, Inc. logo
    KYTX

    Kyverna Therapeutics, Inc.

    Dec 18, 2025
    Purchase
    Indirect
    133.3K shares at avg. $7.50$1000K

1-1 of 1